Welcome to our press area!
This area give you immediate access to timely and relevant corporate information. You will find latest company, business and product information as HTML pages and PDF files.
Readspeaker service: listen to the press information or download the audio file!
DAIICHI SANKYO remains on growth course in Europe
By the end of fiscal year 2012 turnover is forecasted to rise to about €1.2 billion.
DAIICHI SANKYO submits first new drug application for oral factor Xa inhibitor edoxaban
Innovative once-daily oral factor Xa inhibitor submitted for approval in Japan.
DAIICHI SANKYO launches guide on International Women's Day
An educational lifestyle guide designed to help women minimise their risk factors for osteoporosis.
Further press information can be found in:
Press archive 2009
In case of any questions, please do not hesitate to contact us.
